• HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
Wednesday, August 27, 2025
BIOENGINEER.ORG
No Result
View All Result
  • Login
  • HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
  • HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
No Result
View All Result
Bioengineer.org
No Result
View All Result
Home NEWS Science News Biology

Supplements don’t preserve kidney health in Type 2 diabetes

Bioengineer by Bioengineer
November 8, 2019
in Biology
Reading Time: 3 mins read
0
Share on FacebookShare on TwitterShare on LinkedinShare on RedditShare on Telegram

Vitamin D and fish oil don’t prevent loss of kidney function in adults with type 2 diabetes, a clinical study shows.

IMAGE

Credit: Randy Carnell / UW Medicine


Supplements of vitamin D and omega-3 fatty acids (often sold as fish oil) do not help people with type 2 diabetes stave off chronic kidney disease, according to findings from the largest clinical study to date of the supplements in this patient population.

The paper was published Friday, Nov. 8, 2019, in JAMA and presented concurrently at an American Society of Nephrology conference in Washington, D.C.

“We were hopeful for both of these interventions, vitamin D and fish oil, but they don’t appear to be particularly effective for this purpose,” said Dr. Ian de Boer, the paper’s lead author. He is a professor of medicine at the University of Washington School of Medicine and associate director of the Kidney Research Institute, a collaboration of UW Medicine and Northwest Kidney Centers.

Of the 28 million Americans who live with type 2 diabetes, de Boer said, about 40 percent develop chronic kidney disease, a condition in which the kidneys cannot adequately remove waste and fluid from the body. This disrupts a person’s health in myriad ways and can progress to kidney failure. It also greatly increases the risk of cardiovascular events and death.

Previous animal-model and cell-culture studies have suggested that vitamin D and fish oil supplements have anti-inflammatory and other properties that might prevent or slow type 2 diabetes’ progression to chronic kidney disease. Research also has found associations between humans’ kidney decline and lower levels of vitamin D and lower dietary intake of fish.

“A lot of people use the supplements hoping there are beneficial kidney and cardiovascular effects,” de Boer said. “We wanted this study to clarify whether these supplements have any real kidney benefit in adults with diabetes. Even if it’s not the result we hoped for, closing a chapter is useful for patients and clinicians and researchers alike.”

The study was conducted as part of the nationwide VITamin D and OmegA-3 TriaL (VITAL). The investigators designed a five-year study of kidney function in 1,312 adults with type 2 diabetes in the trial. The adults (men aged ?50, women aged ?55) had no clinically apparent cardiovascular disease or cancer, and most did not start with signs of kidney disease.

Participants submitted blood and urine samples to establish a baseline estimated glomerular filtration rate – eGFR, a measure of the kidneys’ waste-filtering performance – and the presence of protein in the urine. They were then randomly assigned to one of four treatment groups:

    370 people received supplements of vitamin D and omega-3 fatty acids (fish oil)

    333 received vitamin D and a fish oil placebo

    289 received a vitamin D placebo and a capsule of fish oil

    320 received two placebos

Blood and urine samples were collected at two years and again at four or five years after randomization. On average, kidney function declined by about 15% over the course of the study. The amount of decline did not vary significantly whether participants were assigned to vitamin D or placebo, or to omega-3 fatty acids or placebo. There were also no significant differences in urine protein excretion.

“The VITAL trial is evaluating the overall benefits and risks of these supplements, and the effects on kidney function are an important piece of the puzzle. The present study answers a key question that helps to advance public health,” said Dr. JoAnn Manson, the study’s senior author and director of the main VITAL trial. She is chief of preventive medicine at Brigham and Women’s Hospital and a professor of medicine at Harvard Medical School.

###

In addition to the University of Washington and Harvard, the research also involved the Department of Biomedical Science at Cedars-Sinai Medical Center in Los Angeles. Funding was provided by the National Institute of Diabetes and Digestive and Kidney Diseases (R01DK088762) and Northwest Kidney Centers.

Media Contact
Brian Donohue
[email protected]
206-543-7856

Original Source

https://newsroom.uw.edu/news/supplements-dont-preserve-kidney-health-type-2-diabetes

Related Journal Article

http://dx.doi.org/10.1001/jama.2019.17380

Tags: DiabetesMedicine/HealthMetabolism/Metabolic DiseasesNutrition/Nutrients
Share12Tweet8Share2ShareShareShare2

Related Posts

blank

CircCOG5 Regulates Ferroptosis in Ovarian Cancer

August 27, 2025
blank

Heat Stress Impact on Aged Hens’ Health and Performance

August 27, 2025

Achieving Weight Goals Within Four Years: A Scientific Breakthrough

August 27, 2025

Exploring Fungal Diversity via Metabarcoding Techniques

August 27, 2025
Please login to join discussion

POPULAR NEWS

  • blank

    Breakthrough in Computer Hardware Advances Solves Complex Optimization Challenges

    148 shares
    Share 59 Tweet 37
  • Molecules in Focus: Capturing the Timeless Dance of Particles

    142 shares
    Share 57 Tweet 36
  • New Drug Formulation Transforms Intravenous Treatments into Rapid Injections

    115 shares
    Share 46 Tweet 29
  • Neuropsychiatric Risks Linked to COVID-19 Revealed

    81 shares
    Share 32 Tweet 20

About

We bring you the latest biotechnology news from best research centers and universities around the world. Check our website.

Follow us

Recent News

Preparing Biomedical Engineers for an Evolving Future

Advancements in Normothermic Regional Perfusion Technologies

Nighttime Light and Noise Impact Seniors’ Sleep Quality

  • Contact Us

Bioengineer.org © Copyright 2023 All Rights Reserved.

Welcome Back!

Login to your account below

Forgotten Password?

Retrieve your password

Please enter your username or email address to reset your password.

Log In
No Result
View All Result
  • Homepages
    • Home Page 1
    • Home Page 2
  • News
  • National
  • Business
  • Health
  • Lifestyle
  • Science

Bioengineer.org © Copyright 2023 All Rights Reserved.